Envestnet Asset Management
BPMC

Envestnet Asset Management’s Blueprint Medicines BPMC Stock Holding History

Envestnet Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,816
Closed -$2.41M – 4526
2025
Q2 		$2.41M Sell
18,816
-21,077
-53% -$2.19M ﹤0.01% 2696
2025
Q1 		$3.53M Buy
39,893
+7,778
+24% +$759K ﹤0.01% 2369
2024
Q4 		$2.8M Buy
32,115
+3,723
+13% +$341K ﹤0.01% 2486
2024
Q3 		$2.63M Buy
28,392
+5,707
+25% +$567K ﹤0.01% 2492
2024
Q2 		$2.44M Sell
22,685
-247
-1% -$24.7K ﹤0.01% 2475
2024
Q1 		$2.18M Buy
22,932
+603
+3% +$51.7K ﹤0.01% 2520
2023
Q4 		$2.06M Buy
22,329
+2,990
+15% +$194K ﹤0.01% 2453
2023
Q3 		$971K Buy
19,339
+3,496
+22% +$187K ﹤0.01% 2836
2023
Q2 		$1M Buy
15,843
+2,193
+16% +$119K ﹤0.01% 2744
2023
Q1 		$614K Buy
13,650
+489
+4% +$22K ﹤0.01% 3017
2022
Q4 		$577K Sell
13,161
-1,232
-9% -$59.1K ﹤0.01% 3019
2022
Q3 		$948K Buy
14,393
+521
+4% +$33.5K ﹤0.01% 2609
2022
Q2 		$701K Buy
13,872
+1,280
+10% +$75K ﹤0.01% 2860
2022
Q1 		$804K Sell
12,592
-1,393
-10% -$100K ﹤0.01% 2812
2021
Q4 		$1.5M Sell
13,985
-3,200
-19% -$335K ﹤0.01% 2352
2021
Q3 		$1.77M Buy
17,185
+678
+4% +$63.1K ﹤0.01% 2168
2021
Q2 		$1.45M Buy
16,507
+2,022
+14% +$185K ﹤0.01% 2282
2021
Q1 		$1.41M Buy
14,485
+2,461
+20% +$246K ﹤0.01% 2174
2020
Q4 		$1.35M Buy
12,024
+1,299
+12% +$137K ﹤0.01% 2010
2020
Q3 		$994K Sell
10,725
-4,577
-30% -$352K ﹤0.01% 2016
2020
Q2 		$1.19M Buy
+15,302
New +$1.03M ﹤0.01% 1863

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Envestnet Asset Management's BPMC Position: Q3 2025 in Review

Envestnet Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 18,816 shares — an estimated $2.41M sold.

Envestnet Asset Management first reported a position in BPMC in Q2 2020 and held it in 21 quarters. The position peaked at $3.53M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Envestnet Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 18,816 Blueprint Medicines shares in Q3 2025, an estimated $2.41M.
  • Envestnet Asset Management first reported a position in Blueprint Medicines in Q2 2020 and held it in 21 quarters.
  • Envestnet Asset Management's Blueprint Medicines position peaked at $3.53M in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Envestnet Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.